Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant

The SARS‐CoV‐2 Omicron BA.1 variant of concern contains more than 30 mutations in the spike protein, with half of these mutations localized in the receptor‐binding domain (RBD). Emerging evidence suggests that these large number of mutations impact the neutralizing efficacy of vaccines and monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhongcheng, Du, Peng, Li, Ning, Xiong, Xinxin, Tang, Shengjun, Dai, Qinjin, Wang, Taorui, Yu, Meixing, Man, Miao, Lam, Kelvin, Baptista‐Hon, Daniel T., Tai, Wa Hou, Monteiro, Olivia, Ng, Weng Sam, Lee, Un Man, Liu, Zhihai, Zhang, Kang, Li, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095991/
https://www.ncbi.nlm.nih.gov/pubmed/35592756
http://dx.doi.org/10.1002/mco2.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095991/
https://www.ncbi.nlm.nih.gov/pubmed/35592756
http://dx.doi.org/10.1002/mco2.143

Ejemplares similares